Description
NSE announces the forthcoming listing of Sudeep Pharma Limited equity shares on the exchange with symbol SUDEEPPHRM and ISIN INE0QPI01025.
Summary
National Stock Exchange of India has issued a circular informing members about the forthcoming listing of equity shares of Sudeep Pharma Limited following its Initial Public Offering (IPO). The company has been assigned the trading symbol SUDEEPPHRM and ISIN INE0QPI01025. The specific listing date will be communicated through a separate circular.
Key Points
- Company Name: Sudeep Pharma Limited
- Trading Symbol: SUDEEPPHRM
- ISIN: INE0QPI01025
- Listing Type: IPO (Initial Public Offering)
- Circular Reference: 2303/2025
- NSE Reference: NSE/CML/71500
- Listing date to be announced separately
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
Exchange members are required to take note of the new listing and prepare their systems for trading in Sudeep Pharma Limited equity shares once the listing date is announced.
Important Dates
- Circular Date: November 27, 2025
- Listing Date: To be announced through separate circular
Impact Assessment
This is a routine listing notification with minimal immediate market impact. The circular serves as an informational notice to exchange members about the upcoming addition of a new security to the trading platform. Trading members should update their systems and be prepared to handle orders for this security once the listing date is confirmed. The actual market impact will depend on the IPO subscription details, price band, and market conditions at the time of listing.
Impact Justification
Standard IPO listing notification with no immediate trading impact. Listing date to be announced separately. Relevant for members tracking new listings.